Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
Psych Congress Steering Committee member Charles Raison, MD, recently spoke with The Sun magazine about depression, diagnosing the disorder, and treatments for it, including antidepressants, psychedelics,...
He talks about which metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD.
...